1	IL-12	IL-12	B-NP	NN	B-protein	2	NMOD	-1
2	inhibition	inhibition	I-NP	NN	O	8	NMOD	18	inhibition
3	of	of	B-PP	IN	O	2	NMOD	-1
4	endothelial	endothelial	B-NP	JJ	O	6	NMOD	-1
5	cell	cell	I-NP	NN	O	6	NMOD	-1
6	functions	function	I-NP	NNS	O	3	PMOD	0
7	and	and	O	CC	O	8	NMOD	-1
8	angiogenesis	angiogenesis	B-NP	NN	O	9	SUB	3	angiogenesis
9	depends	depend	B-VP	VBZ	O	0	ROOT	0
10	on	on	B-PP	IN	O	9	VMOD	-1
11	lymphocyte-endothelial	lymphocyte-endothelial	B-NP	JJ	B-protein	13	NMOD	-1
12	cell	cell	I-NP	NN	I-protein	13	NMOD	-1
13	cross-talk	cross-talk	I-NP	NN	I-protein	10	PMOD	-1
14	.	.	O	.	O	9	P	-1

1	In	In	B-NP	FW	O	2	AMOD	-1
2	vivo	vivo	I-NP	FW	O	3	AMOD	-1
3	IL-12-dependent	IL-12-dependent	I-NP	JJ	O	5	NMOD	17	dependent
4	tumor	tumor	I-NP	NN	O	5	NMOD	-1
5	inhibition	inhibition	I-NP	NN	O	6	SUB	18	inhibition
6	rests	rest	B-VP	VBZ	O	0	ROOT	-1
7	on	on	B-PP	IN	O	6	VMOD	-1
8	the	the	B-NP	DT	O	9	NMOD	-1
9	ability	ability	I-NP	NN	O	7	PMOD	0
10	of	of	B-PP	IN	O	9	NMOD	-1
11	IL-12	IL-12	B-NP	NN	B-protein	10	PMOD	-1
12	to	to	B-VP	TO	O	13	VMOD	-1
13	activate	activate	I-VP	VB	O	9	NMOD	0
14	a	a	B-NP	DT	O	16	NMOD	-1
15	CD8-mediated	CD8-mediated	I-NP	JJ	O	16	NMOD	-1
16	cytotoxicity	cytotoxicity	I-NP	NN	O	13	OBJ	-1
17	,	,	O	,	O	6	P	-1
18	inhibit	inhibit	B-VP	VBP	O	6	VMOD	18	inhibit
19	angiogenesis	angiogenesis	B-NP	NN	O	18	OBJ	3	angiogenesis
20	,	,	O	,	O	6	P	-1
21	and	and	O	CC	O	6	VMOD	-1
22	cause	cause	B-VP	VBP	O	6	VMOD	-1
23	vascular	vascular	B-NP	JJ	O	24	NMOD	-1
24	injury	injury	I-NP	NN	O	22	OBJ	-1
25	.	.	O	.	O	6	P	-1

1	Although	Although	B-SBAR	IN	O	0	ROOT	-1
2	in	in	B-NP	FW	O	3	AMOD	-1
3	vivo	vivo	I-NP	FW	O	4	NMOD	-1
4	studies	study	I-NP	NNS	O	5	SUB	-1
5	have	have	B-VP	VBP	O	1	SBAR	-1
6	shown	show	I-VP	VBN	O	5	VC	-1
7	that	that	B-SBAR	IN	O	6	VMOD	-1
8	such	such	B-NP	JJ	O	9	NMOD	-1
9	inhibition	inhibition	I-NP	NN	O	10	SUB	0
10	stems	stem	B-VP	VBZ	O	31	VMOD	-1
11	from	from	B-PP	IN	O	10	VMOD	-1
12	complex	complex	B-NP	JJ	O	13	NMOD	-1
13	interactions	interaction	I-NP	NNS	O	11	PMOD	0
14	of	of	B-PP	IN	O	13	NMOD	-1
15	immune	immune	B-NP	JJ	B-cell_type	16	NMOD	-1
16	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	-1
17	and	and	O	CC	O	31	VMOD	-1
18	the	the	B-NP	DT	O	19	NMOD	-1
19	production	production	I-NP	NN	O	29	NMOD	9	production
20	of	of	B-PP	IN	O	19	NMOD	-1
21	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	26	NMOD	-1
22	and	and	O	CC	O	26	NMOD	-1
23	other	other	B-NP	JJ	O	26	NMOD	-1
24	downstream	downstream	I-NP	JJ	B-protein	26	NMOD	0
25	angiostatic	angiostatic	I-NP	JJ	I-protein	26	NMOD	-1
26	chemokines	chemokine	I-NP	NNS	I-protein	20	PMOD	-1
27	,	,	O	,	O	29	P	-1
28	the	the	B-NP	DT	O	29	NMOD	-1
29	mechanisms	mechanism	I-NP	NNS	O	31	SUB	-1
30	involved	involve	B-VP	VBN	O	29	NMOD	0
31	are	be	B-VP	VBP	O	7	SBAR	-1
32	still	still	B-ADVP	RB	O	31	VMOD	-1
33	poorly	poorly	B-ADJP	RB	O	34	VMOD	-1
34	defined	define	I-ADJP	VBN	O	31	VC	-1
35	.	.	O	.	O	1	P	-1

1	Here	Here	B-ADVP	RB	O	3	VMOD	-1
2	we	we	B-NP	PRP	O	3	SUB	-1
3	show	show	B-VP	VBP	O	0	ROOT	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	IL-12	IL-12	B-NP	NN	B-protein	6	SUB	-1
6	activates	activate	B-VP	VBZ	O	4	SBAR	17	activates
7	an	an	B-NP	DT	O	9	NMOD	-1
8	anti-angiogenic	anti-angiogenic	I-NP	JJ	O	9	NMOD	3	angiogenic
9	program	program	I-NP	NN	O	6	OBJ	18	program
10	in	in	B-PP	IN	O	6	VMOD	-1
11	Con	Con	B-NP	NNP	B-cell_line	15	NMOD	-1
12	A-activated	A-activated	I-NP	JJ	I-cell_line	15	NMOD	17	activated
13	mouse	mouse	I-NP	NN	I-cell_line	15	NMOD	-1
14	spleen	spleen	I-NP	NN	I-cell_line	15	NMOD	-1
15	cells	cell	I-NP	NNS	I-cell_line	22	NMOD	-1
16	(	(	O	(	O	19	DEP	-1
17	activated	activate	B-NP	VBN	O	18	NMOD	17	activated
18	spc	spc	I-NP	NN	O	19	DEP	-1
19	)	)	O	)	O	15	NMOD	-1
20	or	or	O	CC	O	22	NMOD	-1
21	human	human	B-NP	JJ	O	22	NMOD	-1
22	PBMC	PBMC	I-NP	NN	O	10	PMOD	-1
23	(	(	O	(	O	26	DEP	-1
24	activated	activate	B-NP	VBN	O	25	NMOD	17	activated
25	PBMC	PBMC	I-NP	NN	B-cell_type	26	DEP	-1
26	)	)	O	)	O	22	NMOD	-1
27	.	.	O	.	O	3	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	soluble	soluble	I-NP	JJ	B-protein	3	NMOD	-1
3	factors	factor	I-NP	NNS	I-protein	11	NMOD	-1
4	they	they	B-NP	PRP	O	3	NMOD	-1
5	release	release	B-VP	VBP	O	4	SBAR	0
6	in	in	B-PP	IN	O	5	VMOD	-1
7	its	its	B-NP	PRP$	O	9	NMOD	-1
8	presence	presence	I-NP	NN	O	9	NMOD	0
9	arrest	arrest	I-NP	NN	O	6	PMOD	18	arrest
10	the	the	B-NP	DT	O	11	NMOD	-1
11	cycle	cycle	I-NP	NN	O	19	SUB	0
12	of	of	B-PP	IN	O	11	NMOD	-1
13	endothelial	endothelial	B-NP	JJ	B-cell_type	14	NMOD	-1
14	cells	cell	I-NP	NNS	I-cell_type	12	PMOD	-1
15	(	(	O	(	O	17	DEP	-1
16	EC	EC	B-NP	NN	B-cell_type	17	DEP	-1
17	)	)	O	)	O	14	NMOD	-1
18	,	,	O	,	O	11	P	-1
19	inhibit	inhibit	B-VP	VBP	O	42	VMOD	18	inhibit
20	in	in	B-NP	FW	O	21	AMOD	-1
21	vitro	vitro	I-NP	FW	O	22	NMOD	-1
22	angiogenesis	angiogenesis	I-NP	NN	O	19	OBJ	3	angiogenesis
23	,	,	O	,	O	19	P	-1
24	negatively	negatively	B-ADVP	RB	O	19	VMOD	-1
25	modulate	modulate	B-VP	VBP	O	19	VMOD	0
26	the	the	B-NP	DT	O	27	NMOD	-1
27	production	production	I-NP	NN	O	25	OBJ	9	production
28	of	of	B-PP	IN	O	27	NMOD	-1
29	matrix	matrix	B-NP	NN	B-protein	30	NMOD	-1
30	metalloproteinase-9	metalloproteinase-9	I-NP	NN	I-protein	28	PMOD	-1
31	,	,	O	,	O	42	P	-1
32	and	and	O	CC	O	34	NMOD	-1
33	the	the	B-NP	DT	O	34	NMOD	-1
34	ability	ability	I-NP	NN	O	42	SUB	0
35	of	of	B-PP	IN	O	34	NMOD	-1
36	EC	EC	B-NP	NN	B-cell_type	35	PMOD	-1
37	to	to	B-VP	TO	O	38	VMOD	-1
38	adhere	adhere	I-VP	VB	O	34	NMOD	15	adhere
39	to	to	B-PP	TO	O	38	VMOD	-1
40	vitronectin	vitronectin	B-NP	NN	B-protein	39	PMOD	-1
41	and	and	O	CC	O	42	VMOD	-1
42	up-regulate	up-regulate	B-VP	VBP	O	0	ROOT	17	up-regulate
43	ICAM-1	ICAM-1	B-NP	NN	B-protein	46	NMOD	-1
44	and	and	I-NP	CC	O	46	NMOD	-1
45	VCAM-1	VCAM-1	I-NP	NN	B-protein	46	NMOD	-1
46	expression	expression	I-NP	NN	O	42	OBJ	9	expression
47	.	.	O	.	O	42	P	-1

1	These	These	B-NP	DT	O	2	NMOD	-1
2	effects	effect	I-NP	NNS	O	3	SUB	0
3	do	do	B-VP	VBP	O	11	VMOD	-1
4	not	not	I-VP	RB	O	3	VMOD	-1
5	require	require	I-VP	VB	O	3	VC	16	require
6	direct	direct	B-NP	JJ	O	7	AMOD	-1
7	cell-cell	cell-cell	I-NP	JJ	O	8	NMOD	-1
8	contact	contact	I-NP	NN	O	5	OBJ	15	contact
9	,	,	O	,	O	3	P	-1
10	yet	yet	B-ADVP	RB	O	11	VMOD	-1
11	result	result	B-VP	VBP	O	0	ROOT	-1
12	from	from	B-PP	IN	O	11	VMOD	-1
13	continuous	continuous	B-NP	JJ	O	14	NMOD	-1
14	interaction	interaction	I-NP	NN	O	12	PMOD	15	interaction
15	between	between	B-PP	IN	O	14	NMOD	-1
16	activated	activate	B-NP	VBN	B-cell_type	18	NMOD	17	activated
17	lymphoid	lymphoid	I-NP	JJ	I-cell_type	18	NMOD	-1
18	cells	cell	I-NP	NNS	I-cell_type	20	NMOD	-1
19	and	and	O	CC	O	20	NMOD	-1
20	EC	EC	B-NP	NN	B-cell_type	15	PMOD	-1
21	.	.	O	.	O	11	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	used	use	B-VP	VBD	O	0	ROOT	0
3	neutralizing	neutralize	B-VP	VBG	B-protein	4	NMOD	-1
4	Abs	Ab	B-NP	NNS	I-protein	2	OBJ	-1
5	to	to	B-VP	TO	O	6	VMOD	-1
6	show	show	I-VP	VB	O	2	VMOD	-1
7	that	that	B-SBAR	IN	O	6	VMOD	-1
8	the	the	B-NP	DT	O	10	NMOD	-1
9	IFN-inducible	IFN-inducible	I-NP	JJ	B-protein	10	NMOD	-1
10	protein-10	protein-10	I-NP	NN	I-protein	16	SUB	-1
11	and	and	O	CC	O	12	AMOD	-1
12	monokine-induced	monokine-induced	B-ADJP	JJ	O	10	NMOD	-1
13	by	by	B-PP	IN	O	12	AMOD	-1
14	IFN-gamma	IFN-gamma	B-NP	NN	B-protein	15	NMOD	-1
15	chemokines	chemokine	I-NP	NNS	I-protein	13	PMOD	-1
16	are	be	B-VP	VBP	O	7	SBAR	-1
17	pivotal	pivotal	B-ADJP	JJ	O	16	PRD	-1
18	in	in	B-PP	IN	O	17	AMOD	-1
19	inducing	induce	B-VP	VBG	O	18	PMOD	-1
20	these	these	B-NP	DT	O	21	NMOD	-1
21	effects	effect	I-NP	NNS	O	19	OBJ	0
22	.	.	O	.	O	2	P	-1

1	Experiments	Experiment	B-NP	NNS	O	18	VMOD	-1
2	with	with	B-PP	IN	O	1	NMOD	-1
3	nu/nu	nu/nu	B-NP	NN	O	4	NMOD	-1
4	mice	mouse	I-NP	NNS	O	2	PMOD	-1
5	,	,	O	,	O	18	P	-1
6	nonobese	nonobese	B-NP	JJ	O	8	NMOD	-1
7	diabetic-SCID	diabetic-SCID	I-NP	NN	O	8	NMOD	-1
8	mice	mouse	I-NP	NNS	O	18	SUB	-1
9	,	,	O	,	O	18	P	-1
10	or	or	O	CC	O	12	NMOD	-1
11	activated	activate	B-NP	VBN	O	12	NMOD	17	activated
12	spc	spc	I-NP	NN	O	18	SUB	-1
13	enriched	enrich	B-VP	VBN	O	12	NMOD	-1
14	in	in	B-PP	IN	O	13	VMOD	-1
15	specific	specific	B-NP	JJ	O	17	NMOD	-1
16	cell	cell	I-NP	NN	O	17	NMOD	-1
17	subpopulations	subpopulation	I-NP	NNS	O	14	PMOD	-1
18	demonstrated	demonstrate	B-VP	VBD	O	0	ROOT	-1
19	that	that	B-SBAR	IN	O	18	VMOD	-1
20	CD4	CD4	B-NP	NN	O	33	SUB	-1
21	(	(	O	(	O	23	DEP	-1
22	+	+	B-NP	SYM	O	23	DEP	-1
23	)	)	O	)	O	20	NMOD	-1
24	,	,	O	,	O	33	P	-1
25	CD8	CD8	B-NP	NN	B-protein	33	SUB	-1
26	(	(	O	(	O	28	DEP	-1
27	+	+	B-NP	SYM	O	28	DEP	-1
28	)	)	O	)	O	25	NMOD	-1
29	,	,	O	,	O	33	P	-1
30	and	and	O	CC	O	33	VMOD	-1
31	NK	NK	B-NP	NN	B-cell_type	32	NMOD	-1
32	cells	cell	I-NP	NNS	I-cell_type	33	SUB	-1
33	are	be	B-VP	VBP	O	19	SBAR	-1
34	all	all	O	DT	O	33	VMOD	-1
35	needed	need	B-VP	VBN	O	33	VC	-1
36	to	to	B-VP	TO	O	37	VMOD	-1
37	mediate	mediate	I-VP	VB	O	35	VMOD	16	mediate
38	the	the	B-NP	DT	O	41	NMOD	-1
39	full	full	I-NP	JJ	O	40	AMOD	-1
40	anti-angiogenetic	anti-angiogenetic	I-NP	JJ	O	41	NMOD	3	angiogenetic
41	effect	effect	I-NP	NN	O	37	OBJ	16	effect
42	of	of	B-PP	IN	O	41	NMOD	-1
43	IL-12	IL-12	B-NP	NN	B-protein	42	PMOD	-1
44	.	.	O	.	O	18	P	-1

